South Africa Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Book your hotel early for a discount! You can reap the rewards with great discounts at participating Pullman, M Gallery, Grand Mercure, Novotel, Mercure, ibis and Formule 1 hotels. From our sponsors

South Africa Pharmaceuticals and Healthcare Report Q4 2013 Oct 2nd 2013, 00:00, by swapnil BMI View: This quarter has seen local generic drugmaker Adcock Ingram receive two further non-binding proposals for the company’s takeover, highlighting the long-term commercial opportunities represented by the South African and regional generic drug markets. BMI believes increasing international interest and competition in the local generic drug industry is likely contributing to Aspen Pharmacare’s recent ramp up of its global expansion policy. This ramp up is illustrated by the company’s proposed acquisitions of various multinationals’ business units. Headline Expenditure Projections ? Pharmaceuticals: ZAR30.45bn (US$3.84bn) in 2012 to ZAR34.07bn (US$3.63bn) in 2013; +11.9% in local currency terms and -8.0 % in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118196. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/south-africa-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions